Improving breast cancer risk with pathology, radiology, and genetics
Part of Cancer, Skin clinical trials.
This study looks at tissue, imaging, and genetic information from women who had a non-cancerous breast biopsy to better understand breast cancer risk. It may help improve how we predict and prevent breast cancer in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman
- You are between 18 and 100 years old
- You had a benign (non-cancerous) breast biopsy at Mayo Clinic between 2002 and 2022
- You have never been diagnosed with breast cancer
- You did not develop breast cancer within six months after your benign biopsy
- You have not had both breasts surgically removed to prevent cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how environmental exposures might affect breast cancer risk. It includes women at average risk, high risk, or those diagnosed with breast cancer before age 50, as well as healthcare providers.
This study looks at cancer-related inherited gene changes using blood samples. It may help patients and doctors understand cancer risk and guide treatment planning, especially across different ethnic communities.
This study collects tissue samples and health information from people with breast cancer that has spread or come back. It aims to help researchers learn more about the disease and may lead to better treatments.
This study looks at how well women with a moderate risk of breast cancer follow their screening recommendations (like yearly MRI or mammogram). It may help women who have certain genetic variants or a higher calculated risk stay on top of their breast health.
This study looks for signs in blood samples and imaging that may help estimate breast cancer risk earlier. You would do a mammogram and give blood at the start and then again at yearly follow-up visits.
This study is testing a new way to use your genetic information (along with your family history) to better understand your personal risk for breast cancer. The goal is to see if giving this risk report to women with higher genetic risk can help them and their doctors make more informed decisions about screening and prevention.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.